ARCHIVES

Patient Satisfaction Was Crucial In ODAC Review Of Panretin

This article is from The Cancer Letter archive.

Vol. 24 No. 45 | November 27, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Morgan Named Director Of UAMS Myeloma Institute

April 25, 2014

ODAC Recommends Approval Of Paxen; Will IVAX Break Into $1 Billion Market

September 26, 1997

Phase II Study Of Pfizer Drug Meets Primary Endpoint

April 24, 2009

In Brief: Senate Tracks Reauthorization n New Institute Bill, Waxman May Go Along: Abe Goldin Dies

August 19, 1988

Smaller Ultrasound-Guided Biopsy Needle Safe, Effective, For Suspected Breast Cancer

May 30, 2003

California To Help Uninsured Get Prostate Cancer Therapy.

July 13, 2001